FDA regulatory decisions often lack logical reasoning based on quantitative cost-benefit analysis.
Tag: fda cost-benefit analysis
The NET outcome of lives saved minus lives lost is likely between 11,000 and 115,000 additional deaths each decade due to added delays and costs of the regulatory process.